ADALIMUMAB THERAPY FOR INFLIXIMAB FAILURES IN CROHN'S DISEASE. A SINGLE-CENTRE UK EXPERIENCE

被引：0
|
作者：
Sprakes, M. B. [1 ]
Ford, A. C. [1 ]
Warren, L. [1 ]
Greer, D. [1 ]
Donnellan, C. F. [1 ]
Jennings, J. S. R. [1 ]
Everett, S. M. [1 ]
Hamlin, P. J. [1 ]
机构：
[1] Leeds Gen Infirm, Dept Gastroenterol, Leeds, W Yorkshire, England
来源：
GUT | 2010年 / 59卷
关键词：
D O I：
10.1136/gut.2009.208967h
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A99 / A100
页数：2
相关论文
共 50 条
  • [31] Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
    Haynes, Kevin
    Osterman, Mark T.
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen
    Chen, Lang
    Xie, Fenlong
    Curtis, Jeffrey R.
    Lewis, James D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 359 - 359
  • [32] Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen
    Chen, Lang
    Xie, Fenlong
    Curtis, Jeffrey R.
    Lewis, James D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 811 - U137
  • [33] The safety and efficacy of adalimumab in patients with Crohn's disease: the experience of a single Canadian tertiary care centre
    Teriaky, Anouar
    Gregor, James
    Yan, Brian
    Ponich, Terry
    Chande, Nilesh
    Mosli, Mahmoud
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (03) : 280 - 286
  • [34] Dose escalation of adalimumab and related prognostic factors in patients with Crohn's disease treated with adalimumab maintenance therapy: A single-centre, five-year cohort study
    Nasuno, M.
    Tanaka, H.
    Sugiyama, K.
    Miyakawa, M.
    Motoya, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S314 - S314
  • [35] Efficacy and safety of infliximab versus adalimumab in the treatment of Crohn's disease: The McGill Experience
    Al-Taweel, T.
    Strohl, M.
    Kopylov, U.
    Paradis-Suprenant, L.
    Almaimany, M.
    Martel, M.
    Bitton, A.
    Afif, W.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S369 - S369
  • [36] Muscle function deficits in Crohn's Disease patients treated with Infliximab - tertiary single centre experience
    Spiric, J.
    Vuksanovic, S.
    Toplicanin, A.
    Nikolic, A.
    Jovicic, T.
    Jovicic, I
    Djuranovic, S.
    Popovic, D.
    Markovic, A. Pavlovic
    Djelic, M.
    Sokic-Milutinovic, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1837 - i1837
  • [37] Adalimumab Therapy in Children With Crohn Disease Previously Treated With Infliximab
    Cozijnsen, Martinus
    Duif, Vera
    Kokke, Freddy
    Kindermann, Angelika
    van Rheenen, Patrick
    de Meij, Tim
    Schaart, Maaike
    Damen, Gerard
    Norbruis, Obbe
    Pelleboer, Rolf
    Van den Neucker, Anita
    van Wering, Herbert
    Hummel, Thalia
    Oudshoorn, Johanna
    Escher, Johanna
    de Ridder, Lissy
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 60 (02): : 205 - 210
  • [38] The use of adalimumab in refractory Crohn's disease: A tertiary referral centre experience
    Ho, G.
    Smith, L.
    Aitken, S.
    Rose, J.
    Ruddell, B.
    Bramley, P.
    Palmer, K.
    Arnott, I.
    Shand, A.
    Satsangi, J.
    GUT, 2007, 56 : A1 - A1
  • [39] Efficacy of Adalimumab Therapy in Patients with Crohn's Disease Who Were Unresponsive to or Intolerant of Infliximab: Six Years of Experience in a Single Gastroenterology Center
    Shafran, Ira
    Cangemi, David
    Burgunder, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S444 - S444
  • [40] Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series
    Cordero Ruiz, Patricia
    Castro Marquez, Cristina
    Mendez Rufian, Vanesa
    Castro Laria, Luisa
    Caunedo Alvarez, Angel
    Romero Vazquez, Javier
    Herrerias Gutierrez, Juan Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (06) : 294 - 298
12345